The goal of this activity is for learners to be better able to identify the role of SGLT inhibition in HF prevention and treatment; evaluate the latest clinical safety, efficacy, and cost-effectiveness evidence for the use of SGLT inhibition in patients with HF; define practical considerations for SGLT inhibition in patients with HF; and understand how to implement GDMT with SGLT inhibition in individual treatment plans in accordance with the latest clinical evidence and guideline recommendations.
- Provider:Medscape, LLC
- Activity Link: https://www.medscape.org
- Start Date: 2024-05-16 05:00:00
- End Date: 2024-05-16 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - Commercial Support: Source: Lexicon Pharmaceuticals, Inc. - Amount: 79827.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest